Macter International has been growing earnings at an average annual rate of 27%, while the Life Sciences industry saw earnings growing at 6.3% annually. Revenues have been growing at an average rate of 17.5% per year. Macter International's return on equity is 20.4%, and it has net margins of 6.8%.
Key information
27.03%
Earnings growth rate
22.31%
EPS growth rate
Life Sciences Industry Growth
26.83%
Revenue growth rate
17.54%
Return on equity
20.44%
Net Margin
6.82%
Last Earnings Update
31 Mar 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Macter International makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
KASE:MACTER Revenue, expenses and earnings (PKR Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
11,955
816
4,087
0
31 Dec 25
11,584
815
3,800
0
30 Sep 25
10,962
835
3,509
0
30 Jun 25
10,360
776
3,274
0
31 Mar 25
9,894
611
3,154
0
31 Dec 24
9,310
603
2,920
0
30 Sep 24
8,484
469
2,713
0
30 Jun 24
7,975
407
2,568
0
31 Mar 24
7,272
351
2,483
0
31 Dec 23
6,823
325
2,353
0
30 Sep 23
6,672
253
2,304
0
30 Jun 23
6,926
357
2,257
0
31 Mar 23
6,807
269
2,318
0
31 Dec 22
6,833
341
2,244
0
30 Sep 22
6,315
357
2,137
0
30 Jun 22
5,612
292
1,949
0
31 Mar 22
5,707
456
1,834
0
31 Dec 21
5,410
349
1,763
0
30 Sep 21
5,308
267
1,726
0
30 Jun 21
5,373
226
1,713
0
31 Mar 21
5,315
123
1,630
0
31 Dec 20
5,728
138
1,709
0
30 Sep 20
5,908
72
1,825
0
30 Jun 20
5,705
-28
1,841
0
31 Mar 20
5,503
8
1,892
0
31 Dec 19
4,940
-37
1,808
0
30 Sep 19
4,466
-37
1,662
0
30 Jun 19
4,195
70
1,563
0
31 Mar 19
3,853
13
1,509
0
31 Dec 18
3,855
117
1,438
0
30 Sep 18
4,001
229
1,402
0
30 Jun 18
4,053
246
1,396
0
30 Jun 16
3,064
147
0
0
Quality Earnings: MACTER has a high level of non-cash earnings.
Growing Profit Margin: MACTER's current net profit margins (6.8%) are higher than last year (6.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MACTER's earnings have grown significantly by 27% per year over the past 5 years.
Accelerating Growth: MACTER's earnings growth over the past year (33.5%) exceeds its 5-year average (27% per year).
Earnings vs Industry: MACTER earnings growth over the past year (33.5%) exceeded the Life Sciences industry 19.1%.
Return on Equity
High ROE: MACTER's Return on Equity (20.4%) is considered high.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/07/15 21:43
End of Day Share Price
2026/07/15 00:00
Earnings
2026/03/31
Annual Earnings
2025/06/30
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Macter International Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.